Amplifyer Bio Analysis: $7M Raised
What is Amplifyer Bio?
Novel priming agents for liquid biopsy diagnostics
Location
Cambridge, United States
Employees
1-10
Founded
2023
Product Features & Capabilities
- Priming agents to increase cfDNA in blood
- Enhances genomic information quality for cancer diagnostics
- Improves clinical outcomes in oncology
Use Cases
Improve cancer diagnostics by increasing cfDNA in blood; Enhance genomic information quality for oncology patients; Improve clinical outcomes in cancer care
Other Considerations
Founded by Dr. Sangeeta Bhatia, Dr. Chris Love, and Dr. Viktor Adalsteinsson; Research published in Science; Presented at leading international conferences; MIT and Broad Institute collaboration
See something that needs updating? Suggest edits to this profile.